ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2020
Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19.
Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression.Journal of medical virology · 2021Pooled it
- Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis.Frontiers in medicine · 2020Pooled it
- Article
- A comment-driven evidence appraisal approach to promoting research findings into practice when only uncertain evidence is available.Health research policy and systems · 2023Article
- Association between IL-6 polymorphisms and Atopic Dermatitis in Chinese Han children.Frontiers in pediatrics · 2023Article
- Use of Multiple Doses of Intravenous Infusion of Umbilical Cord-Mesenchymal Stem Cells for the Treatment of Adult Patients with Severe COVID-19-Related Acute Respiratory Distress Syndrome: Literature Review.Stem cells international · 2023Review
- Review
- An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19).International immunopharmacology · 2022Review
- Identification and Development of Therapeutics for COVID-19.mSystems · 2021Article
- A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital.Journal of epidemiology and global health · 2021Observational
- Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis.World journal of methodology · 2021Article
- Circulating Calprotectin as a Biomarker of COVID-19 Severity.Expert review of clinical immunology · 2021Review
- Cardiac abnormalities due to multisystem inflammatory syndrome temporally associated with Covid-19 among children: A systematic review andInternational journal of cardiology. Heart & vasculature · 2021Review
- Article
- Challenges of Cellular Therapy During the COVID-19 Pandemic.Advances in experimental medicine and biology · 2021Article
- Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021Review
- The effect of tocilizumab on cytokine release syndrome in COVID-19 patients.Pharmacological reports : PR · 2020Article
- The role of Interleukin 6 inhibitors in therapy of severe COVID-19.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020Review
- Cardiac Involvement in Children With COVID-19.Indian pediatrics · 2020Article
- Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.Molecular biomedicine · 2020Review
Corrections and comments
- Comment on
- Comment on
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.